A biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies and immunotherapies, with a primary emphasis on oncology. Its pipeline includes several small‑molecule cancer drugs developed in-house and in partnership with global pharmaceutical companie...
No congressional trades have been disclosed for HUTCHMED (China) Ltd (HCM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.